This inventor holds 1 USPTO granted patent. Top assignee: Shaanxi University of Science and Technology. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Haizhen Mo: Innovator in Antibacterial Hydrogel Applications
Introduction
Haizhen Mo is a notable inventor based in Xi'an, China. He has made significant contributions to the field of antibacterial treatments through his innovative research and patent applications. His work focuses on the application of hydrogels in the preparation of products aimed at treating bacterial infections.
Latest Patents
Haizhen Mo holds a patent for the "Application of a hydrogel in the preparation of products for the treatment of bacterial infections." This patent reveals the use of ferrous ions in antibacterial activity tests, demonstrating a strong bactericidal effect. The survival rate of bacteria was found to be less than 0.001%, while the survival rate of methicillin-resistant Staphylococcus aureus (MRSA) was less than 0.01%. The ferrous ion hydrogel has shown promise in treating keratitis and skin wound infections. It significantly reduces the risk of pulmonary MRSA infection, prevents the dissimilation of MRSA to the lungs, and alleviates systemic inflammation in a timely and effective manner. This highlights the therapeutic potential of ferrous compounds in treating various infections, including MRSA.
Career Highlights
Haizhen Mo is affiliated with the Shaanxi University of Science and Technology, where he conducts his research and development work. His innovative approach to using hydrogels in medical applications has garnered attention in the scientific community.
Collaborations
Haizhen Mo collaborates with several colleagues, including Dan Xu and Zhen Wang, who contribute to his research efforts and advancements in the field.
Conclusion
Haizhen Mo's work in the development of antibacterial hydrogels represents a significant advancement in medical treatments for bacterial infections. His innovative research continues to pave the way for new therapeutic options in combating resistant bacterial strains.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile